[Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?]

Gastroenterol Hepatol. 2003 May;26(5):325-9. doi: 10.1016/s0210-5705(03)70366-5.
[Article in Spanish]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Anti-Bacterial Agents*
  • Anti-Ulcer Agents / administration & dosage
  • Anti-Ulcer Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Drug Resistance
  • Drug Resistance, Multiple, Bacterial
  • Drug Therapy, Combination / administration & dosage
  • Drug Therapy, Combination / therapeutic use*
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / therapeutic use
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects
  • Histamine H2 Antagonists / administration & dosage
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Organometallic Compounds / therapeutic use
  • Proton Pump Inhibitors
  • Ranitidine / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Enzyme Inhibitors
  • Histamine H2 Antagonists
  • Organometallic Compounds
  • Proton Pump Inhibitors
  • Ranitidine
  • bismuth tripotassium dicitrate